Literature DB >> 15516972

Prognostic implication of laminin-5 gamma 2 chain expression in the invasive front of colorectal cancers, disclosed by area-specific four-point tissue microarrays.

Eiji Shinto1, Hitoshi Tsuda, Hideki Ueno, Yojiro Hashiguchi, Kazuo Hase, Seiichi Tamai, Hidetaka Mochizuki, Johji Inazawa, Osamu Matsubara.   

Abstract

The laminin-5 gamma 2 chain (LN-5gamma2) is known to be a marker of invasion in several cancer types. Our purpose was to examine the prognostic significance of LN-5gamma2 expression in different areas of individual colorectal cancers (CRCs) by using tissue microarrays (TMAs), and to clarify the optimal areas for prognostic assessment. Using formalin-fixed paraffin-embedded tissue blocks of pT3 primary CRCs resected from 120 patients, we constructed TMA blocks of tissue core specimens taken from the submucosal invasive front, subserosal invasive front, central area, and rolled edge of each tumor. Using these four-point TMA sets, cytoplasmic LN-5gamma2 expression was immunohistochemically surveyed, and the area-specific prognostic significance of LN-5gamma2 expression was evaluated. The data revealed that 35, 30, 15 and 10% of the 120 CRCs showed high-grade LN-5gamma2 expression in the submucosal invasive front, subserosal invasive front, central area and rolled edge, respectively. Disease-specific survival curves for the groups with high- and low-grade LN-5gamma2 in the submucosal invasive front and subserosal invasive front were different significantly or of marginal difference (respective 5-year survival rates: 54 and 78% for submucosal invasive front (P=0.030) and 58 and 75% for subserosal invasive front (P=0.055)). Multivariate analysis revealed that the grades of LN-5gamma2 expression in submucosal invasive front (hazard ratio=2.0, P=0.047) and subserosal invasive front (hazard ratio=2.9, P=0.0033) were independent prognostic factors. In contrast, the grades of LN-5gamma2 expression in the central area and rolled edge did not have a significant impact on patient prognosis. Analysis using area-specific four-point TMAs clearly demonstrated that LN-5gamma2 expression in the invasive front largely influences the degree of clinical aggressiveness of CRC and its tendency to metastasize.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15516972     DOI: 10.1038/labinvest.3700199

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  19 in total

Review 1.  Laminin-332-integrin interaction: a target for cancer therapy?

Authors:  Daisuke Tsuruta; Hiromi Kobayashi; Hisayoshi Imanishi; Koji Sugawara; Masamitsu Ishii; Jonathan C R Jones
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 2.  Novel translational strategies in colorectal cancer research.

Authors:  Ignacio Gil-Bazo
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

3.  Clinicopathological significance of MMP-7, laminin γ2 and EGFR expression at the invasive front of gastric carcinoma.

Authors:  Kazuhiro Sentani; Miho Matsuda; Naohide Oue; Naohiro Uraoka; Yutaka Naito; Naoya Sakamoto; Wataru Yasui
Journal:  Gastric Cancer       Date:  2013-09-19       Impact factor: 7.370

4.  Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription.

Authors:  R Fukuyama; R Niculaita; K P Ng; E Obusez; J Sanchez; M Kalady; P P Aung; G Casey; N Sizemore
Journal:  Oncogene       Date:  2008-06-30       Impact factor: 9.867

Review 5.  Defining the role of laminin-332 in carcinoma.

Authors:  Cherise M Guess; Vito Quaranta
Journal:  Matrix Biol       Date:  2009-08-15       Impact factor: 11.583

6.  Hypoxic conditions induce a cancer-like phenotype in human breast epithelial cells.

Authors:  Marica Vaapil; Karolina Helczynska; René Villadsen; Ole W Petersen; Elisabet Johansson; Siv Beckman; Christer Larsson; Sven Påhlman; Annika Jögi
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

7.  Tumor-infiltrating immune cells: triggers for tumor capsule disruption and tumor progression?

Authors:  Bin Jiang; Jeffrey Mason; Anahid Jewett; Min-ling Liu; Wen Chen; Jun Qian; Yijiang Ding; Shuqing Ding; Min Ni; Xichen Zhang; Yan-gao Man
Journal:  Int J Med Sci       Date:  2013-03-05       Impact factor: 3.738

8.  Human subperitoneal fibroblast and cancer cell interaction creates microenvironment that enhances tumor progression and metastasis.

Authors:  Motohiro Kojima; Youichi Higuchi; Mitsuru Yokota; Genichiro Ishii; Norio Saito; Kazuhiko Aoyagi; Hiroki Sasaki; Atsushi Ochiai
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

9.  Tumor budding is a significant indicator of a poor prognosis in lung squamous cell carcinoma patients.

Authors:  Ryota Masuda; Hiroshi Kijima; Naoko Imamura; Naohiro Aruga; Yusuke Nakamura; Daisuke Masuda; Haruka Takeichi; Nobusuke Kato; Tomoki Nakagawa; Makiko Tanaka; Sadaki Inokuchi; Masayuki Iwazaki
Journal:  Mol Med Rep       Date:  2012-08-27       Impact factor: 2.952

10.  Evidence-based Guidelines for Precision Risk Stratification-Based Screening (PRSBS) for Colorectal Cancer: Lessons learned from the US Armed Forces: Consensus and Future Directions.

Authors:  Itzhak Avital; Russell C Langan; Thomas A Summers; Scott R Steele; Scott A Waldman; Vadim Backman; Judy Yee; Aviram Nissan; Patrick Young; Craig Womeldorph; Paul Mancusco; Renee Mueller; Khristian Noto; Warren Grundfest; Anton J Bilchik; Mladjan Protic; Martin Daumer; John Eberhardt; Yan Gao Man; Björn Ldm Brücher; Alexander Stojadinovic
Journal:  J Cancer       Date:  2013-03-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.